Literature DB >> 21932109

Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Laura L Hurley1, Robert E Taylor, Yousef Tizabi.   

Abstract

Nicotine and alcohol are two of the most commonly abused legal substances. Heavy use of one drug can often lead to, or is predictive of, heavy use of the other drug in adolescents and adults. Heavy drinking and smoking alone are of significant health hazard. The combination of the two, however, can result in synergistic adverse effects particularly in incidences of various cancers (e.g., esophagus). Although detrimental consequences of smoking are well established, nicotine by itself might possess positive and even therapeutic potential. Similarly, alcohol at low or moderated doses may confer beneficial health effects. These opposing findings have generated considerable interest in how these drugs act. Here we will briefly review the negative impact of drinking-smoking co-morbidity followed by factors that appear to contribute to the high rate of co-use of alcohol and nicotine. Our main focus will be on what research is telling us about the central actions and interactions of these drugs, and what has been elucidated about the mechanisms of their positive and negative effects. We will conclude by making suggestions for future research in this area.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21932109      PMCID: PMC3377362          DOI: 10.1007/s12640-011-9275-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  243 in total

Review 1.  Central nicotinic receptors, neurotrophic factors and neuroprotection.

Authors:  N Belluardo; G Mudò; M Blum; K Fuxe
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

2.  Depressive characteristics of FSL rats: involvement of central nicotinic receptors.

Authors:  Y Tizabi; A H Rezvani1; L T Russell; K Y Tyler; D H Overstreet
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

3.  SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample.

Authors:  N R Hoft; R P Corley; M B McQueen; D Huizinga; S Menard; M A Ehringer
Journal:  Genes Brain Behav       Date:  2009-03-23       Impact factor: 3.449

Review 4.  Genetic approaches to addiction: genes and alcohol.

Authors:  Francesca Ducci; David Goldman
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

5.  Nicotine decreases blood alcohol concentrations in adult rats: a phenomenon potentially related to gastric function.

Authors:  Scott E Parnell; James R West; Wei-Jung A Chen
Journal:  Alcohol Clin Exp Res       Date:  2006-08       Impact factor: 3.455

6.  Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons.

Authors:  Ekrem Maloku; Bashkim Kadriu; Adrian Zhubi; Erbo Dong; Fabio Pibiri; Rosalba Satta; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-03-02       Impact factor: 7.853

7.  Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.

Authors:  Noritaka Ariyoshi; Masami Miyamoto; Yuri Umetsu; Hideo Kunitoh; Hirotoshi Dosaka-Akita; Yu-Ichi Sawamura; Jun Yokota; Nobuo Nemoto; Kunio Sato; Tetsuya Kamataki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-09       Impact factor: 4.254

8.  Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.

Authors:  H L Tripathi; B R Martin; M D Aceto
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

9.  A twin-family study of alcoholism in women.

Authors:  K S Kendler; M C Neale; A C Heath; R C Kessler; L J Eaves
Journal:  Am J Psychiatry       Date:  1994-05       Impact factor: 18.112

Review 10.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.

Authors:  Makoto Naoi; Wakako Maruyama; Georgy M Nagy
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  30 in total

Review 1.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

2.  PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.

Authors:  Sridharan Manavalan; Bruk Getachew; Kebreten F Manaye; Syed J Khundmiri; Antonei B Csoka; Raechel McKinley; Andrea Tamas; Dora Reglodi; Yousef Tizabi
Journal:  Neurotox Res       Date:  2017-03-24       Impact factor: 3.911

Review 3.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

4.  Nicotinic Mechanisms Modulate Ethanol Withdrawal and Modify Time Course and Symptoms Severity of Simultaneous Withdrawal from Alcohol and Nicotine.

Authors:  Erika Perez; Natalia Quijano-Cardé; Mariella De Biasi
Journal:  Neuropsychopharmacology       Date:  2015-03-19       Impact factor: 7.853

5.  GWAS and network analysis of co-occurring nicotine and alcohol dependence identifies significantly associated alleles and network.

Authors:  Bo Xiang; Bao-Zhu Yang; Hang Zhou; Henry Kranzler; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-11-28       Impact factor: 3.568

6.  Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study.

Authors:  Sterling M McPherson; Ekaterina Burduli; Crystal Lederhos Smith; Olivia Brooks; Michael F Orr; Celestina Barbosa-Leiker; Trynke Hoekstra; Michael G McDonell; Sean M Murphy; Matthew Layton; John M Roll
Journal:  Exp Clin Psychopharmacol       Date:  2018-08-27       Impact factor: 3.157

7.  Nicotine decreases ethanol-induced dopamine signaling and increases self-administration via stress hormones.

Authors:  William M Doyon; Yu Dong; Alexey Ostroumov; Alyse M Thomas; Tao A Zhang; John A Dani
Journal:  Neuron       Date:  2013-07-18       Impact factor: 17.173

8.  A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.

Authors:  Raye Z Litten; Megan L Ryan; Joanne B Fertig; Daniel E Falk; Bankole Johnson; Kelly E Dunn; Alan I Green; Helen M Pettinati; Domenic A Ciraulo; Ofra Sarid-Segal; Kyle Kampman; Mary F Brunette; Eric C Strain; Nassima A Tiouririne; Janet Ransom; Charles Scott; Robert Stout
Journal:  J Addict Med       Date:  2013 Jul-Aug       Impact factor: 3.702

9.  Implicit alcohol cognitions in risky drinking nicotine users with and without co-morbid major depressive disorder.

Authors:  Amy M Cohn; Caroline Cobb; Brett T Hagman; Amy Cameron; Sarah Ehlke; Jessica N Mitchell
Journal:  Addict Behav       Date:  2013-12-19       Impact factor: 3.913

Review 10.  Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers.

Authors:  Megan M Yardley; Michael M Mirbaba; Lara A Ray
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.